65,437 trials
Neuroendocrine Tumors
Primary: Sensitivity of 64Cu-DOTATATE PET-CT Imaging for Detection of Somatostatin Receptor Positive SSTR (+) Tumor — 30; 3 Participants
Pathology
Primary: Major Discordance Rate — 3.5; 3.1 Percentage of Major Discordances
Idiopathic Pulmonary Fibrosis
Primary: EGCG PK Level in Healthy Volunteers — NA; NA; NA; 861 nM
Anterior Cruciate Ligament Rupture
Primary: International Knee Documentation Committee (IKDC) Questionnaire Score — 47.40; 50.80; 61.83; 52.86 score on a scale — p=0.0219
Dental Caries
Primary: Antimicrobial Activity of C16G2 — -0.49; 0.23; -0.44; -0.31 CFU/mL
Sensory Peripheral Neuropathy · Balance; Distorted · Sensation Disorders
Primary: Functional Gait Assessment — 14.8; 14.8; 14.8; 17.0 score on a scale
Gastrointestinal Neoplasms
Primary: Fatigue Interference Subscale of Fatigue Symptom Inventory — 3.93; 3.47; 4.27; 4.26 units on a scale — p=0.60
HIV Infections
Primary: Proportion of Participants Surviving With Viral Suppression — 0.494; 0.353 proportion of participants
Cataract
Primary: Anterior Chamber Cell Grade — 38; 7 Participants
Smokeless Tobacco Use · Tobacco Dependence
Primary: Extent of Toxicity: Mean of Median Values of NNK+NNN in 7 Smokeless Tobacco Brands — 2.4; 2.25; 3.19; 5.51 ug/g
Osteo Arthritis Knee
Primary: Pain Catastrophizing Scale (PCS) at Day 2 — 20.40; 15.25 score on a scale
Post-traumatic Stress Disorder
Primary: Number of Participants With Assessment Retention Assessment Retention — 24; 25 Participants
Primary Myelofibrosis · Post-polycythemia Vera Myelofibrosis · Post-essential Thrombocythemia Myelofibrosis
Primary: Total Symptom Score (TSS) Response Rate at Week 24 — 24.62; 9.23 Percentage of participants — p=0.0095
Pathology
Primary: Overall Percentage Agreement of Repeatability and Reproducibility Within Scanner, Between Scanners, and Sites. — 94.5; 92.4; 93.4 Average Positive Agreement Rate
Advanced Dry Macular Degeneration
Primary: Level of Alpha Melanocyte Stimulating Hormone as Measured by Enzyme-linked Immunosorbent Assay